INSIGHTS ON PHARMACEUTICAL PACKAGING

PHARMACEUTICAL PACKAGING SOLUTIONS

  • Leveraging over 20 years of experience in injectable packaging, PCI supports multiple delivery forms from Phase I through commercialization.

  • A generic drug must contain the same active ingredients as the original formulation. According to the U.S. Food and Drug Administration (FDA), generic drugs are identical or within an acceptable bioequivalent range to the brand-name counterpart with respect to pharmacokinetic and pharmacodynamic properties.

  • Examine a dual‑mode approach that delivers precise, repeatable detection for both micro‑defects and larger breaches. Strengthen packaging quality and reduce investigation cycles with this platform.

  • The BE high-speed solution performs a stable production of up to 800 blisters per minute – day and night. Reliability and robustness have served as guiding principles for our machine design. Thanks to 100% modularity, it also allows entire functions to be easily added or replaced at a later date. This means you are always equipped for changing requirements and applications.

  • A flexible technical field‑services program offers multi‑vendor laboratory instrument support, facility services, relocations, and environmental qualifications to optimize operations, reduce risk, and maintain compliance.